Larvol Delta - Assessing-the-Safety-and-Efficacy-of-MYMD1-to-Treat-Depression-in-Patients-With-PostAcute-Sequelae-of-Coronavirus-Disease2019-PASC

isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci

http://clinicaltrials.gov/ct2/show/NCT05242003

Feb 16, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next